08 Aug 2024 --- Kyowa Hakko Bio’s 2’-Fucosyllactose (2’-FL) human milk oligosaccharide (HMO) receives approval as a novel food ingredient by the EU’s European Commission (EC). The Kirin Holdings Company subsidiary says the approval allows its 2’-FL HMO ingredient—its third EC-approved HMO—to be incorporated into several food categories, including infant formula, follow-on formula, foods for medical purposes and food supplements, across 27 EU member states.
